Ethos Financial Group LLC Takes $1.15 Million Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Ethos Financial Group LLC purchased a total of 65,823 shares of Sabra Healthcare REIT, Inc., valued at about $1,150,000, as reported in a recent Form 13F filing with the SEC.
• Sabra Healthcare REIT has announced a quarterly dividend of $0.30, representing an annual yield of 6.5%, with the ex-dividend date set for August 15th.
• The company exceeded earnings expectations with $0.38 earnings per share for the last quarter, surpassing analyst estimates by $0.02, and reported a 7.4% increase in revenue year-over-year.

Ethos Financial Group LLC purchased a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 65,823 shares of the real estate investment trust's stock, valued at approximately $1,150,000.

Other institutional investors have also added to or reduced their stakes in the company. UMB Bank n.a. grew its position in Sabra Healthcare REIT by 379.6% in the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after purchasing an additional 1,621 shares in the last quarter. Assetmark Inc. grew its position in Sabra Healthcare REIT by 37.8% in the 1st quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after purchasing an additional 989 shares in the last quarter. Fifth Third Bancorp grew its position in Sabra Healthcare REIT by 110.3% in the 1st quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock worth $67,000 after purchasing an additional 2,011 shares in the last quarter. GF Fund Management CO. LTD. bought a new stake in Sabra Healthcare REIT in the 4th quarter worth about $74,000. Finally, Harbor Capital Advisors Inc. grew its position in Sabra Healthcare REIT by 17.2% in the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after purchasing an additional 642 shares in the last quarter. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Price Performance

NASDAQ:SBRA traded down $0.0410 during mid-day trading on Friday, hitting $19.5790. 1,487,244 shares of the stock traded hands, compared to its average volume of 2,451,063. The business's 50-day moving average price is $18.42 and its 200 day moving average price is $17.67. The company has a market cap of $4.69 billion, a PE ratio of 25.78, a price-to-earnings-growth ratio of 1.55 and a beta of 0.86. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The firm had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The company's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the company posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. Sabra Healthcare REIT's dividend payout ratio is 157.89%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on SBRA shares. Scotiabank upped their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. JMP Securities lifted their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $20.00.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.